These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 538075)

  • 1. [Pharmaceutical technology problems in the preparation of drugs for the treatment of cardiovascular diseases].
    Moldenhauer H
    Pharmazie; 1979 Aug; 34(8):500-6. PubMed ID: 538075
    [No Abstract]   [Full Text] [Related]  

  • 2. Nanomedicine applied to cardiovascular diseases: latest developments.
    Martín Giménez VM; Kassuha DE; Manucha W
    Ther Adv Cardiovasc Dis; 2017 Apr; 11(4):133-142. PubMed ID: 28198204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of cardiovascular drugs in pregnancy].
    Halawa B
    Wiad Lek; 1989 Jan; 42(2):94-100. PubMed ID: 2683387
    [No Abstract]   [Full Text] [Related]  

  • 4. [The efficacy and safety of the drug treatment of cardiovascular diseases].
    Mazur NA
    Ter Arkh; 1993; 65(8):4-7. PubMed ID: 8211800
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular drug therapy in the elderly.
    Aronow WS; Frishman WH; Cheng-Lai A
    Heart Dis; 2000; 2(2):151-67. PubMed ID: 11728253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic implications of the gender-specific aspects of cardiovascular disease.
    Regitz-Zagrosek V
    Nat Rev Drug Discov; 2006 May; 5(5):425-38. PubMed ID: 16672926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The newest critical care drugs.
    Chase SL
    RN; 1999 May; 62(5):34-9; quiz 40. PubMed ID: 10418524
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse dermatologic effects of cardiovascular drug therapy.
    Brosnan BD; Frishman WH; Sun DK; Grossman M
    Heart Dis; 2000; 2(3):220-47. PubMed ID: 11728264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of randomised clinical trials of cardiovascular generic versus brand name drugs.
    Cardiovasc J Afr; 2009; 20(2):143. PubMed ID: 19421653
    [No Abstract]   [Full Text] [Related]  

  • 10. [Methods of evaluating drug therapy, particularly in cardiovascular diseases].
    Lövy O; Toman J
    Cesk Zdrav; 1984 Sep; 32(8-9):361-5. PubMed ID: 6509673
    [No Abstract]   [Full Text] [Related]  

  • 11. [The best of clinical cardiovascular pharmacology in 2005].
    Ambrosi R; Andrejak M; Drici MD; Herpin D;
    Arch Mal Coeur Vaiss; 2006 Jan; 99 Spec No 1(1):95-9. PubMed ID: 16479971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New cardiovascular-active drugs].
    Bölter C
    Z Arztl Fortbild (Jena); 1984; 78(19):797-800. PubMed ID: 6506791
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rationale for the pharmacologic treatment of cardiovascular diseases].
    Perdigão C
    Rev Port Cardiol; 1998 May; 17(5):453-61. PubMed ID: 9656768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacologic and therapeutic peculiarities in the aged, especially in the cardiovascular diseases].
    Klaus W
    Z Kardiol; 1985; 74 Suppl 7():27-31. PubMed ID: 2868583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An analysis of pharmacotherapy in an internal medicine ambulatory care clinic, using the example of cardiovascular-effective drugs].
    Conen D; Zschokke U; Dubach UC
    Schweiz Med Wochenschr; 1981 Aug; 111(31-32):1163-8. PubMed ID: 7280625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems in scientific drug therapy from a socio-hygienic point of view].
    Kobler A; Lehmann G
    Z Arztl Fortbild (Jena); 1981 Oct; 75(19):906-8. PubMed ID: 7314685
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiology drug update. Foreword.
    Crawford MH
    Cardiol Clin; 2008 Nov; 26(4):xi. PubMed ID: 18929226
    [No Abstract]   [Full Text] [Related]  

  • 18. What future does the pharmaceutical industry have in the cardiovascular world?
    Braunwald E
    Eur Heart J; 2013 Apr; 34(13):943-4. PubMed ID: 23546415
    [No Abstract]   [Full Text] [Related]  

  • 19. A population-based study on well-being in the very old: the role of cardiovascular diseases and drugs.
    Westerbotn M; Agüero-Torres H; Fastbom J; Hillerås P
    Arch Gerontol Geriatr; 2005; 40(3):287-97. PubMed ID: 15814162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PHARMAC and cardiovascular health in New Zealand.
    Moodie P
    N Z Med J; 2008 Mar; 121(1270):102-5. PubMed ID: 18364762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.